GlassScriptPhysician profile
Nathan Edward Gilbert
NPI 1255087839
$687.69
in general payments reported to CMS, 2019-2025
15 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.59 · 2023: $145 · 2024: $175 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $141.05 | 2024-2025 | Imfinzi |
| Seagen INC. | $124.26 | 2023 | Tukysa |
| Genentech USA, INC. | $120.47 | 2022-2025 | Polivy |
| Janssen Scientific Affairs, LLC | $50.50 | 2024 | Rybrevant, Akeega, Talvey |
| Merck Sharp & Dohme LLC | $27.48 | 2025 | Keytruda, Keytruda Qlex |
| Adaptive Biotechnologies Corporation | $27.20 | 2025 | Clonoseq |
| Corcept Therapeutics | $26.70 | 2025 | Korlym |
| Sobi, INC | $25.12 | 2025 | |
| Becton, Dickinson and Company | $23.06 | 2025 | Allpoints |
| Takeda Pharmaceuticals U.S.A., INC. | $22.93 | 2025 | Fruzaqla |
| Novartis Pharmaceuticals Corporation | $22.37 | 2025 | |
| Pharmaessentia USA Corporation | $21.15 | 2025 | Besremi |
| Siemens Medical Solutions USA, INC. | $20.51 | 2023 | Truebeam, Aria Radiation Therapy Management Software |
| Bayer Healthcare Pharmaceuticals INC. | $17.87 | 2025 | |
| Celgene Corporation | $17.02 | 2025 | Reblozyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.